IDEXX Laboratories Inc.

IDXX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $1.97B $1.78B $1.60B $1.49B $1.38B $1.30B $1.22B $1.10B
Companion Animal Group $1.68B $1.50B $1.33B $1.22B $1.12B $1.04B $960.1M $861.4M
Water $111.8M $103.2M $94.0M $89.2M $83.8M $79.8M $77.6M $71.8M
Livestock Poultry and Dairy $129.9M $128.1M $123.5M $126.8M $123.4M $124.2M $121.6M $110.7M
Other $43.5M $41.2M $52.2M $51.9M $53.1M $56.1M $60.9M $58.7M
Cost of Revenue $871.7M $800.0M $711.6M $669.7M $620.9M $594.2M $572.2M $524.8M
Gross Profit $1.10B $975.4M $890.3M $816.1M $756.1M $699.1M $646.5M $578.6M
Gross Margin 55.7% 54.9% 55.6% 54.9% 54.8% 53.9% 53.0% 52.5%
Operating Expenses
Research & Development $109.2M $101.1M $99.7M $98.3M $88.0M $82.0M $76.0M $68.6M
SG&A Expense $220.9M $207.0M $182.5M $173.9M $157.9M $137.6M $129.4M $126.5M
Operating Income $413.0M $350.2M $299.9M $260.3M $266.8M $262.6M $236.2M $203.9M
Operating Margin 21.0% 19.7% 18.7% 17.5% 19.3% 20.3% 19.4% 18.5%
Interest Expense $37.2M $32.0M $29.2M $15.4M $5.4M $3.8M $3.5M $2.4M
Pretax Income $381.1M $321.8M $273.1M $246.6M $263.3M $260.6M $234.4M $202.1M
Income Tax Expense $117.8M $99.8M $81.0M $64.6M $75.5M $82.3M $72.7M $60.8M
Net Income $263.1M $222.0M $192.1M $181.9M $187.8M $178.3M $161.8M $141.3M
Net Margin 13.4% 12.5% 12.0% 12.2% 13.6% 13.7% 13.3% 12.8%
EPS (Basic) $3.00 $2.47 $2.07 $1.82 $1.77 $3.24 $2.85 $2.45
EPS (Diluted) $2.94 $2.44 $2.05 $1.79 $1.74 $3.17 $2.78 $2.37
Shares Outstanding (Basic) 87.8M 89.7M 92.6M 100.1M 106.3M 55.0M 56.8M 57.7M
Shares Outstanding (Diluted) 89.6M 90.9M 93.6M 101.5M 108.0M 56.2M 58.2M 59.6M
Dividends Per Share
← Newer Page 2 of 3 Older →